Radiation Research – September Issue

The September 2021 issue of Radiation Research is now available online.

If your institutional library has a BioOne subscription and you are using your institution portal,

you may access the Abstracts, Full Text, and PDFs at http://www.bioone.org/toc/rare/current
 

If your institution does not have a BioOne subscription or you are not using

your institution portal, you may log in as a member

at http://www.radres.org/?page=IssuesArchives

 

 

FUNDING OPPORTUNITIES

 

New RNCP and NIH Funding Opportunities

 

 

  • Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) (PAR-21-326)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): December 01, 2021. This Funding Opportunity Announcement (FOA) invites qualified academic or research institutions to apply for support to purchase and install advanced equipment to enhance and modernize research-supporting operations of biomedical research facilities. Targeted are core facilities, animal research facilities, and other research spaces that are used on a shared basis. The goal of this FOA is to strengthen research-auxiliary activities of biomedical research facilities and to enhance the efficacy of their operation.  

 

  • The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) (RFA-CA-21-059) National Cancer Institute. Application Receipt Date(s): November 18, 2021. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers

 

UPCOMING EVENTS

 

  • The International Conference on the Development of Preparedness for National and International Emergency Response (EPR2021), with be held from 11 – 15 October 2021 in Vienna, Austria. (if COVID-19 restrictions persist the Conference will be held virtually on the same dates). The purpose of the Conference is to foster exchange of information and enhance global awareness on various EPR topics through the discussion of both the progress made at national and international levels and the challenges encountered, by sharing experiences, evaluating current trends, technologies and lessons in EPR and identifying key priorities in further improving readiness for nuclear and radiological incidents and emergencies, regardless whether they arise from an accident, natural disaster, negligence, nuclear security event or any other cause. Further information about the Conference can be found here.

 

  • BARDA is pleased to announce that our exciting Lightning Talks showcase will once again be a part of BARDA Industry Day 2021 (BID2021). This year’s theme is Strengthening Partnerships, Advancing Innovation and the 2-day agenda on November 3 & 4, 2021, highlights the many ways we collaborate with our stakeholders to continually enhance our medical countermeasure capabilities and efficiencies. Lightning Talks are for individuals, academic institutions, pharmaceutical, and biotech companies, and other industry innovators to showcase their innovative technologies while continuously fostering critical connections. In 2021, Lightning Talks will showcase innovative discoveries and promote stakeholder networking through virtual conference introductions. Lightning Talks will be featured during both afternoon sessions, and we are anticipating a large audience of industry partners and stakeholder participants this year. Applying to present a Lightning Talk is easy—just submit up to 500 words and one PowerPoint slide (optional) on a proposed presentation using the portal on our website.

 

 

 

RECENT PUBLICATIONS

 

Promises, Pitfalls and Future Directions - Key Session ConRad 2021”

 

Dr. Sally Amundson and colleagues discuss five areas in gene expression (GE) for biodosimetry and effect prediction purposes pointing at promises, pitfalls and future directions at the ConRad 2021 (Global Conference on Radiation Topics). [Int J Radiat Biol. 2021 Oct 4;1-21] Online ahead of print.

 

Patrick Ostheim, Sally A Amundson, Christophe Badie, Dimitry Bazyka, Angela C Evans, Shanaz A Ghandhi, Maria Gomolka, Milagrosa López Riego, Peter K Rogan, Robert Terbrueggen, Gayle E Woloschak, Frederic Zenhausern, Hanns L Kaatsch, Simone Schüle, Reinhard Ullmann, Matthias Port, Michael Abend

 

 

Read more:

“Gene Expression for Biodosimetry and Effect Prediction Purposes: Promises, Pitfalls and Future Directions - Key Session ConRad 2021”

 

 

 JOB OPPORTUNITIES

  • Researcher in Medical Radiation Physics, Stockholm University. The position will be associated with the project SINFONIA - Radiation risk appraisal for detrimental effects from medical exposure during management of patients with lymphoma or brain tumor (Home - Sinfonia (sinfonia-appraisal.eu) funded from the Euratom research and training program). The project is focused on the development of a comprehensive system for personalized dosimetry in radiotherapy accounting for stray radiation dose and the risks associated with it. Personalized models of patients will be used with analytical algorithms to estimate dose distributions in out-of-field and partially exposed organs during photon radiation therapy.
  • Postdoctoral Fellow - Health Disparities, Cancer and Radiation Response. Thomas Jefferson University - Philadelphia, Pennsylvania. The Simone Laboratory in the Radiation Oncology Department at Thomas Jefferson University Hospital in Philadelphia, PA is seeking an outstanding post-doctoral fellow to work in the area of cancer, health disparities and radiation biology. This position will focus on understanding the molecular underpinnings of the disparate cancer treatment populations. This will focus on preclinical models and also analysis of clinical trial samples. Our laboratory is translational and has significant experience taking our preclinical findings to the clinic and anticipate the findings here to build our next clinical trial experience. This NIH funded work will focus on using dietary interventions to decrease health disparities across models.